Evidence map›Paper›PMID 35810159›Full record

ArticleCell death discovery2022

The role of NLRP3 inflammasome in psychotropic drug-induced hepatotoxicity.

Wenqing Mu, Guang Xu, Ziying Wei, Zhilei Wang, Qin Qin, Li Lin, Lutong Ren, Tingting Liu, Zhie Fang, Yan Yang and 5 more

Open access · goldAbstract read
In one paragraph

Article in Cell death discovery, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 2 institutions in 1 country.

Wenqing Mu *Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Guang Xu *Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China. guang_xu@ccmu.edu.cn.ORCID http://orcid.org/0000-0001-9960-6894
Ziying Wei *Department of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Zhilei WangDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Qin QinDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Li LinDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Lutong RenDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Tingting LiuDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Zhie FangDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Yan YangDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Jing ZhaoDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Junnan WangDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Xiaoyan ZhanDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Xiaohe XiaoDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China. pharmacy_302@126.com.ORCID http://orcid.org/0000-0002-2836-2738
Zhaofang BaiDepartment of Hepatology, the Fifth Medical Center of PLA General Hospital, Beijing, 100039, China. baizf2008@hotmail.com.ORCID http://orcid.org/0000-0002-6208-150X
Chinese PLA General Hospital · CNCapital Medical University · CN

Funding

Beijing Nova Program Z181100006218001National Natural Science Foundation of China (National Science Foundation of China) 81630100National Natural Science Foundation of China (National Science Foundation of China) 81874368
6 · The paper itself

Abstract

Increased medical application of psychotropic drugs raised attention concerning their toxicological effects. In fact, more than 160 psychotropic drugs including antidepressants and antipsychotics, have been shown to cause liver side effects, but the underlying mechanisms are still poorly understood. Here, we discovered that fluoxetine, a common antidepressant, was specifically sensed by NLRP3 inflammasome, whose subsequent activation resulted in the maturation of caspase-1 and IL-1β, as well as gasdermin D (GSDMD) cleavage, which could be completely abrogated by a selective NLRP3 inhibitor MCC950 or Nlrp3 knockout (Nlrp3

Identifiers

PMID35810159
PMCPMC9271040
OpenAlexW4284961712

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.